Author

Karin Séron

Centre National de la Recherche ScientifiqueORCID 0000-0002-9667-133XUnclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Assay:metabolomics· 1

Frequent Co-Authors

Anne GoffardiD· 1 shared Audrey Tarricone· 1 shared Céline RivièreiD· 1 shared Charline Camuzet· 1 shared Cyril RobiliD· 1 shared F. Silva Angulo· 1 shared François TrotteiniD· 1 shared Guillaume LefèvreiD· 1 shared

Activity by Year

2024-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMicrobiology

Anne GoffardORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Major Metabolites From Hypericum perforatum L., Hyperforin And Hypericin, Are Both Active Against Human Coronaviruses

Imelda Raczkiewicz, Céline Rivière, Peggy Bouquet, Lowiese M. B. Desmarets, Audrey Tarricone, Charline Camuzet, Nadine François, Guillaume Lefèvre, Jennifer Samaillie, F. Silva Angulo, Cyril Robil, François Trottein, Sevser Şahpaz, J. D. Dubuisson, Sandrine Belouzard, , Karin Séron

This study shows that hyperforin from Hypericum perforatum inhibits multiple coronaviruses, including SARS-CoV-2, with antiviral activity confirmed in human cells and potential for combination therapy with remdesivir.

bioRxiv · Apr 9, 2024 · PreprintMicrobiology